Caduet (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Caduet drug offered from Pfizer Laboratories Div Pfizer Inc. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
| NON-PROPRIETARY NAME: | amlodipine besylate and atorvastatin calcium |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2004-01-30 |
| END MARKETING DATE: | 0000-00-00 |
Caduet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Caduet from Pfizer Laboratories Div Pfizer Inc |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2004-01-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-2150_6722a493-1a03-49cb-8541-136acc657033 |
| PRODUCT NDC: | 0069-2150 |
| APPLICATION NUMBER: | NDA021540 |
Other AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATE Pharmaceutical Manufacturers / Labelers:
